TARS vs TECH
Tarsus Pharmaceuticals Inc (TARS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported TARS revenue for 2024-12-31 was $183.0M. Net income was -$115.6M. Revenue was up 948.6% from 2023-12-31 to 2024-12-31. TARS currently screens at market cap $2.66B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
TARS currently screens at market cap $2.66B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the TARS and TECH stock pages for the full models.
Not investment advice.